%D7%A8%D7%A7%D7%A2-01_edited.jpg

CorNeat Vision's Synthetic Cornea Approved for First-in-Human Implantation

July 14, 2020

New Hope for the Corneally Blind Provides Definitive Protection from COVID-19 Transmission

RA'ANANA, Israel, July 14, 2020 /PRNewswire/ -- The CorNeat KPro, the first synthetic cornea that bio-integrates with the eye wall, received approval to begin a clinical trial at Beilinson Hospital, Israel. The clinical trial, approved by Israel's Ministry of Health, will include 10 corneally blind patients who are not candidates for, or have failed one or more corneal transplantations. The CorNeat KPro first-in-human implantation will be led by Professor Irit Bahar, Director of the Ophthalmology Department at Beilinson Hospital. Additional sites are planned to open later this year in eight leading hospitals in Canada, the United States, France, China and the Netherlands.

Read more here:
https://www.prnewswire.com/news-releases/corneat-visions-synthetic-cornea-approved-for-first-in-human-implantation-301093020.html

%D7%A8%D7%A7%D7%A2-01_edited.jpg

info@corneat.com

Visit us at
4 HaSheizaf St.

Ra'anana, Israel

Join Our Mailing List